Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06793748 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer
A Phase 1 study, sponsored by Rion.
- Not yet
- Registry status
- Phase 1
- Development phase
- 184
- Enrollment target
NCT06793748 is a Phase 1 study that has not yet begun recruiting, run by Rion. The registered enrollment target is 184 participants.
The verdict
NCT06793748, a Phase 1 study, has not yet begun recruiting, sponsored by Rion.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 184 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if drug Purified Exosome Product (PEP™) and Fibrin Sealant (TISSEEL® VH SD Kit) (PEP-TISSEEL) works to treat chronic radiation ulcer in adults and compare it with comparator TISSEEL. It will also learn about the safety of drug PEP-TISSEEL.
Interventions
- COMBINATION_PRODUCT PEP-TISSEEL
- DRUG TISSEEL Fibrin Sealant KIT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2025-06 |
| Est. Completion | 2026-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06793748
The ClinicalTrials.gov registry entry for NCT06793748 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rion, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PEP-TISSEEL is the first listed.
NCT06793748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06793748 about?
NCT06793748 is a clinical study titled "Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer". The goal of this clinical trial is to learn if drug Purified Exosome Product (PEP™) and Fibrin Sealant (TISSEEL® VH SD Kit) (PEP-TISSEEL) works to treat chronic radiation ulcer in adults and compare it with comparator TISSEEL. It will also learn about the safety of drug PEP-TISSEEL.
What is the current status of trial NCT06793748?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 184 participants. The study started on 2025-06. Estimated completion is 2026-02.
What interventions are being tested in trial NCT06793748?
The interventions under investigation include: PEP-TISSEEL (COMBINATION_PRODUCT), TISSEEL Fibrin Sealant KIT (DRUG).
Who is sponsoring clinical trial NCT06793748?
This trial is sponsored by Rion, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.